These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of metastasizing breast cancer with anabolic steroids]. Hortling H; Malmio K Nord Med; 1967 Mar; 77(9):275-9. PubMed ID: 6020758 [No Abstract] [Full Text] [Related]
3. [On the hormonal treatment of metastatic mammary carcinoma]. Pickert H Ther Ggw; 1965 Oct; 104(10):1327-37. PubMed ID: 5879858 [No Abstract] [Full Text] [Related]
4. [The present position of hormone treatment of metastasizing cancer diseases]. Martz G Praxis; 1967 Nov; 56(48):1625-9. PubMed ID: 5632548 [No Abstract] [Full Text] [Related]
5. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases. El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812 [TBL] [Abstract][Full Text] [Related]
6. [Results of hormonal treatment of breast cancer with special reference to preventive therapy]. Schmidt H; Bauer R Strahlentherapie; 1968 Sep; 136(3):259-62. PubMed ID: 5685748 [No Abstract] [Full Text] [Related]
7. [Therapy of the metastasizing mammary carcinoma]. Studer H; Dolder M Schweiz Med Wochenschr; 1966 Feb; 96(8):250-3. PubMed ID: 5983011 [No Abstract] [Full Text] [Related]
8. PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST. NISSEN-MEYER R Clin Radiol; 1964 Apr; 15():152-60. PubMed ID: 14140852 [No Abstract] [Full Text] [Related]
9. [Letter: Prednisone treatment of breast cancer with metastases]. Billund JK Ugeskr Laeger; 1974 Jun; 136(24):1306. PubMed ID: 4840262 [No Abstract] [Full Text] [Related]
10. [Breast cancer with distant metastases]. Solheim OP Tidsskr Nor Laegeforen; 1976 Feb; 96(6):361-4, 373. PubMed ID: 1257972 [No Abstract] [Full Text] [Related]
11. [A controlled clinical trial for hormonal and combined cyclophosphamide-hormonal treatment of incurable breast cancer (author's transl)]. Wolff G; Prahl B Arch Geschwulstforsch; 1973; 41(4):363-72. PubMed ID: 4747050 [No Abstract] [Full Text] [Related]
12. [Therapy of advanced mammary carcinomas with high-dosed cytostatics]. Boeckl O; Heitz N; Wasl H; Karrer K; Mannheimer E Munch Med Wochenschr; 1965 Oct; 107(43):2114-8. PubMed ID: 5899028 [No Abstract] [Full Text] [Related]
14. Management of breast cancer. Cohen IA; Keller JH; Abate MA Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963 [TBL] [Abstract][Full Text] [Related]
15. Macrophage activity and hormonal responsiveness in mammary cancer. George WD; Partridge W; Burn JI Br J Surg; 1973 Apr; 60(4):317. PubMed ID: 4700268 [No Abstract] [Full Text] [Related]
16. Hormonal therapy of breast cancer: state of the art. Murphy B; Muss HB Oncology (Williston Park); 1997 May; 11(5 Suppl 4):7-13. PubMed ID: 9165500 [TBL] [Abstract][Full Text] [Related]
17. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?]. Rochefort H C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098 [TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy of cancer of the female breast. Meakin JW Appl Ther; 1969 Feb; 11(2):84-7. PubMed ID: 5777753 [No Abstract] [Full Text] [Related]
19. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. Meakin JW; Allt WE; Beale FA; Bush RS; Clark RM; Fitzpatrick PJ; Hawkins NV; Jenkin RD; Pringle JF; Reid JG; Rider WD; Hayward JL; Bulbrook RD Eur J Cancer (1965); 1980; Suppl 1():179-81. PubMed ID: 7032930 [No Abstract] [Full Text] [Related]
20. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations. Smalley RV; Bartolucci AA Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861 [No Abstract] [Full Text] [Related] [Next] [New Search]